Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and can be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
What We Do
Our analysts identify opportunities in which digital therapeutics can significantly impact clinical and economic outcomes for high-risk populations.
Our team of medical doctors and scientists research and recommend the best, clinically validated methods of addressing the opportunity.
Our user experience and design team masterfully create a beautiful and engaging application.
In compliance with industry regulations and standards, our engineering team makes it work seamlessly and scalably.
Our data scientists author rigorous statistical algorithms that adapt our therapeutic mechanisms to each user’s particular neurological profile.
We work with leading academic institutions to pilot and prove significant clinical and economic benefit.
We customize and integrate the application to fit within our partner’s existing infrastructure, and provide success-only billing based on improved outcomes. Our partners are provided with a real-time data analytics portal including metrics on engagement, behavior changes, endpoint achievement, and ROI based on projected and realized cost savings.
Everyone wins. Patients win by gaining access to more effective treatments, and our partners win by increasing profits and improving clinical outcomes.
Payers reduce healthcare spending and increase profits by optimizing health maintenance and disease prevention across covered lives.
Health care providers deliver more effective and efficient care to their patients while enhancing morbidity and mortality outcomes.
Pharmaceutical companies augment effect size, increase patient share, improve adherence, and de-risk drug development initiatives.
CT-100: Click Neurobehavioral Intervention (CNI) Platform
Smoking Cessation
Myocardial Infarction
Chronic Pain
Depressed Mood
Major Depressive Disorder
What is a digital therapeutic?
Digital therapeutics utilize software to treat a disease, and may also include ancillary components such as connected hardware device(s), adjunctive pharmacotherapy, or live clinical support, but the software component could still drive meaningful outcomes as an independent contributor to treatment.
Tap the button below to evaluate if a product is designed to be a Digital Therapeutic!
Clinical trial of Clickotine, a digital therapeutics solution for smoking cessation: design and telehealth execution methodology

Steinerman et al. (2016)
CNS Summit

Clickotine, a personalized smartphone app for smoking cessation: initial evaluation

Iacoviello et al. (2017)
JMIR mHealth and uHealth

Six-month outcomes from Clickotine: a digital therapeutic program for smoking cessation

Iacoviello et al. (2017)
Society for Research on Nicotine and Tobacco

Self-reported depression and anxiety during a smoking cessation quit-aid trial

Saleem et al. (2017)
Association for Psychological Science

Adherence to smoking cessation medication among Clickotine users

Iacoviello et al. (2017)
Connected Health Conference

Cognitive-emotional training as an intervention for major depressive disorder

Iacoviello et al. (2014)
Depression and Anxiety

Developing cognitive-emotional training exercises as interventions for mood and anxiety disorders

Iacoviello et al. (2015)
European Psychiatry

Neuroscience-informed cognitive-affective training interventions for mood and anxiety disorders

Alvarez et al. (2015)
Current Treatment Options in Psychiatry

Evaluating the efficacy of a cognitive-emotional training Intervention for depression

Hoch et al. (2017)
Society of Biological Psychiatry

David B. Klein
Chief Executive Officer
Victor Gao
Chief Innovation Officer
Wei Zhou
Chief Experience Officer
Ted Silver
Chief Financial Officer
Joel Sangerman
Chief Commercial Officer
Christopher Jordan
Chief Technology Officer
Brian Iacoviello, PhD
Director of Scientific Affairs
Michael Ng
Director of Engineering
Jacob Choi
Design Director
Hannar Lee
Daniel Shin
Data Scientist
Matthew Springer
Fuhe Xu
Adam Gao
Data Engineer
Sasinda Premarathna
Infrastructure Engineer
Liz Germana, LCSW
Community Manager
Sarah Jackson
Joshua Steinerman, MD
Chief Neuroscientist
Bruce Leuchter, MD
Senior Advisor
Nik Schork, PhD
Jonathan Sporn, M.D.
Scientific Advisor
Seth Feuerstein, MD
Sean Luo, MD, PhD
Scientific Advisor
Maria Forero
Strategic Advisor
Meir Kryger, MD
Senior Scientific Advisor
Barry Fine, MD, PhD
Scientific Advisor
Gina Kruse, MD
Scientific Advisor
Adam Berger
Technology Advisor
Tavis Allison
Grants Advisor
David Benshoof Klein
Executive Chairman, Interim President & CEO
  • Former Managing Director at Opus Point & Co., a hedge fund and private equity firm dedicated to life science investing
  • 14+ years life science industry experience; key roles in founding, developing & financing >10 life science companies
  • Co-Founder & Owner at Klein Sun Gallery, America's leading Chinese contemporary art gallery
  • Guest Lecturer, Biotechnology Program at Columbia University
  • Former Senior Consultant at Pfizer & Strategic Advisor at publicly traded & privately held life science companies
  • B.A., Brandeis University
Victor Gao
Vice Chairman, Chief Innovation & Engagement Officer
  • Former Senior VP, Structured Products Trading at Cerberus Capital Management
  • Former VP, Financial Analytics & Structured Transactions Group at Bear Stearns
  • Former Associate, Credit Derivative Structuring at Credit Suisse
  • Former Chief Technology Officer at (later
  • B.A., Cum Laude, Biochemistry & Computational Neuroscience, Harvard University
Wei Zhou
Chief Experience Officer
  • Former Partner & Head of Product at &
  • Former UX / Art Director at Isobar
  • Former User Experience Designer at Microsoft & Mozilla
  • Significant experience leading the design of mobile healthcare applications
  • MFA, Graphic Design, Yale University; MDes, Interaction Design, Carnegie Mellon University; B.A/S., Animation & Multimedia/Computer Science, Tsinghua University (#1 in Chinese National Entrance Exam)
Ted Silver, CMA
Chief Financial Officer
  • Former Senior Medical Technology Analyst at Visium Asset Management
  • Former Section Head, Medical Technology at Amaranth Advisors
  • Former Equity Research Associate, Medical Technology at Pequot Capital
  • MBA, Yale University; B.A., Swarthmore College
Joel Sangerman
Chief Commercial Officer
  • Former VP of Sales, Managed Markets at Zillion Health
  • Former Area VP of Sales, Market Development at Walgreens Infusion Services / Option Care
  • Former Director of Payor Relations, Managed Markets, Reimbursement at Johnson & Johnson
  • Former Director of Reimbursement at Cell Therapeutics
  • Former National Account Manager, Managed Markets at Aventis Pharmaceuticals
  • B.S., Cum Laude, Marketing, DePaul University
Christopher Jordan
Chief Technology Officer
  • Former Engineering Manager at Bloomberg LP
  • Former Senior Team Lead, Research & Development at Bloomberg LP
  • Former Developer at Bloomberg LP
  • B.S.E., Computer Engineering, University of Michigan
Brian Iacoviello, PhD
Director of Scientific Affairs
  • Assistant Professor of Psychiatry, Icahn School of Medicine at Mount Sinai
  • Former Director of Psychotherapy Research, Mood and Anxiety Disorders Program at Mount Sinai
  • Conducting over $1m in NIH and foundation-funded research investigating neurobehavioral interventions for mood and anxiety disorders
  • Former Visiting Lecturer at Princeton University
  • Adjunct Instructor at Temple University
  • Ph.D. and M.A., Clinical Psychology, Temple University; B.A. with Honors, Psychology and Entrepreneurship & Management, Johns Hopkins University
Michael Ng
Director of Engineering
  • Former Senior iOS Developer at Paperless Post
  • Former Software Engineer at SocialFlow
  • Former Software Engineer at UBS
  • B.A., Computer Science & Philosophy, Amherst College
Jacob Seokhoon Choi
Design Director
  • Former Visual Designer at Victoria Productions
  • Former Senior UI Designer at HUMAX
  • Winner, IF Design Award; Silver, IDEA (International Design Excellence Awards); Finalist, Adobe Design Achievement Award; Grand Prize, The Symbol of Korea Design Award
  • B.A., Graphic Design, Kookmin University
Hannar Lee
  • Former iOS Developer at CREAM Style
  • Former Research Assistant at NYU Wireless
  • B.A., Computer Science & Mathematics, New York University
Daniel Shin
Data Scientist
  • Former Data Scientist at IBM
  • Former Data Science Fellow at Metis
  • Former Researcher at Weill Cornell Medical College & NYU Langone Medical Center
  • B.A., Biochemistry, New York University
Matthew Springer
  • Former Software Engineer at Geonetics
  • Former Assistant Project Estimator at Barletta Engineering Co.
  • Former Assistant Project Engineer at Consigli Construction
  • B.S., Computer Science, Northeastern University
Fuhe Xu
  • Former Full Stack Developer at Kuma Games
  • Former Web Tools Developer at
  • Former QA Software Engineer at Audiocodes
  • B.S.E., Computer Engineering, Purdue University
Adam Gao
Data Engineer
  • Former Data Integration at Minsheng Royal Fund Management
  • Former Data Analyst at Deloitte China
  • M.A., Statistics, Columbia University; B.S., Applied Mathematics, Peking University
Sasinda Premarathna
Infrastructure Engineer
  • Former Software Engineer at Oath
  • Former Software Engineer at Cake, Inc.
  • Former Android Developer at XWiki
  • M.S., Information Systems, Cornell University; B.S., Computer Science and Engineering, University of Moratuwa
Liz Germana, LCSW
Community Manager
  • Former Clinical Consultant & Outpatient Therapist at Adaptive Behavioral Services
  • Former Clinical Social Worker at Children’s Hospital of Pittsburgh of UPMC
  • Former Behavioral Specialist Consultant & Mobile Therapist at Youth Advocate Programs
  • MSW, University of Pittsburgh; B.A., Indiana University of Pennsylvania
Sarah Jackson
  • Former eCHART Training Coordinator at Erlanger Health System
  • Former Research Assistant, Daniel Gilbert Lab at Harvard University
  • Former Research Assistant, Sidanius Lab in Intergroup Relations at Harvard University
  • B.A., Cum Laude, Cognitive Neuroscience & Evolutionary Psychology, Harvard University
Joshua R. Steinerman, M.D.
Chief Neuroscientist
  • Founder at ProGevity Neuroscience
  • Senior Director at Teva Pharmaceuticals
  • Former Assistant Professor of Neurology at Albert Einstein College of Medicine
  • Completed Neurology residency at Yale School of Medicine
  • Cognitive Neuropsychiatry fellowship at Columbia University Medical Center
  • M.D., SUNY-Downstate College of Medicine; A.B., Magna Cum Laude, Harvard University
Bruce Leuchter, M.D.
Senior Advisor
  • Managing Director at PJT Partners
  • Assistant Professor of Psychiatry at Weill Cornell Medical College
  • Former Director, Healthcare Investment Banking at Credit Suisse
  • Former Director, Clinical Neuropsychiatry at Weill Cornell Medical College
  • Former Biotechnology Analyst, Global Investment Research at Goldman Sachs & Company
  • M.D., Wayne State University School of Medicine; B.A., with Honors and High Distinction, University of Michigan
Nicholas J. Schork, Ph.D.
Director & Senior Scientific Advisor
  • Professor & Director of Human Biology at the J. Craig Venter Institute
  • Member, Board of Directors at MD Revolution
  • Adjunct Professor of Psychiatry and Family and Preventative Medicine at University of California San Diego
  • Former Director of Biostatistics & Bioinformatics at Scripps Translational Science Institute; Former Director of Research at Scripps Genomic Medicine
  • Former Professor of Biostatistics & Psychiatry & Co-Director of the Center for Human Genetics & Genomics at University of California San Diego
  • Former Associate Professor of Epidemiology & Biostatistics at Case Western Reserve University
  • Former Adjunct Associate Professor of Biostatistics at Harvard University
  • Ph.D., Epidemiology, University of Michigan; M.A., Statistics, University of Michigan; M.A. & B.A., Philosophy, University of Michigan
Jonathan Sporn, MD
Scientific Advisor
  • Founder at Perception Neuroscience, a biotechnology company developing novel, fast-acting antidepressants
  • Former Senior Director at Pfizer
  • Former Associate Director, Neurology and Psychiatry, Pharmaceutical Research and Development at Johnson & Johnson
  • Former Senior Clinical Fellow, Mood and Anxiety Disorder Program at National Institute of Mental Health
  • Former Clinical Associate, Psychiatry and Research at Massachusetts General Hospital
  • M.D., University of Miami Medical School; B.S., Zoology, Duke University
Seth Feuerstein, MD
Director & Senior Advisor
  • Chief Medical/Innovation Officer at Magellan Health
  • Founded and sold Cobalt Therapeutics, a premier cognitive behavioral therapy software company
  • Psychiatrist, Office of Forensic Evaluations at Connecticut Department of Mental Health and Addiction Services
  • Assistant Clinical Professor, Department of Psychiatry at Yale University School of Medicine
  • Advisory Board Member, Center for Biomedical Interventional Technology at Yale University
  • Former Board of Directors at HistoRx
  • Former President & CEO at Carigent Therapeutics
  • Former Principal & Co-Founder at Elm Street Ventures
  • J.D. and M.D., New York University; B.S., Biology, Cornell University
Sean X. Luo, M.D., Ph.D.
Scientific Advisor
  • Leon Levy Fellow, Division of Substance Abuse at Columbia University
  • Significant prior experience in developing Precision Medicine solutions for substance use disorders
  • Completed residency in Psychiatry at Columbia University & the New York State Psychiatric Institute
  • M.D., Columbia University College of Physicians and Surgeons; Ph.D., Computational Neuroscience and Machine Learning, Columbia University; B.A., University of Chicago
Maria Forero
Board Observer & Strategic Advisor
  • Principal & General Partner at Ridgetop Health (former Aelius Healthcare Innovations Fund)
  • Former Head of Sales & Marketing at Sandoz Latin America
  • Former CEO/GM of Spain & Portugal at Novartis Vaccines & Diagnostics
  • Former Vice President & Global Healthcare Marketing Analyst at Morgan Stanley
  • Former Audit Manager at PwC
  • MPH, Columbia University; BSc, Human Genetics, University College London
Meir Kryger, MD
Senior Scientific Advisor
  • Director, National Sleep Foundation
  • Program Director & Professor of Pulmonary, Critical Care & Sleep Medicine at Yale School of Medicine
  • Former President of the American Academy of Sleep Medicine; Former President of the Canadian Sleep Society
  • Chief Editor of the most widely used textbook in sleep medicine: The Principles and Practice of Sleep Medicine
  • Physician at the VA Connecticut Health System
  • Former Director of Research and Education at Gaylord Sleep Medicine
  • M.D., McGill University; B.Sc., McGill University
Barry Fine, MD, PhD
Scientific Advisor
  • Associate Professor of Medicine, Cardiology at Columbia University Medical Center
  • Post-Doctoral Research Fellow, Laboratory for Stem Cell Regeneration at Columbia University Medical Center
  • Clinical Fellow, Cardiovascular Medicine at New York Presbyterian Hospital
  • Completed residency in Internal Medicine at New York Presbyterian Hospital
  • MD, Columbia University College of Physicians and Surgeons; PhD, Columbia University; BS, cum laude and Distinction, Yale University
Gina Kruse, MD
Scientific Advisor
  • Assistant Professor of Medicine at Massachusetts General Hospital
  • Assistant Professor at Harvard Medical School
  • Investigator, Tobacco Research and Treatment Center at Harvard Medical School
  • M.D., Baylor College of Medicine; M.P.H., School of Public Health, Harvard University; M.S., Health Services Research,Texas Tech University; B.S., Animal Sciences, Iowa State University
Adam Berger
Director of Data Engineering
  • Engineering Manager at Uber
  • Former Director of Data Engineering at Click Therapeutics
  • Former Team Lead, Machine Learning at Bloomberg LP
  • Former Developer, Analytics & Infrastructure at Bloomberg LP
  • Founder at Ezbds LLC
  • B.S., Cum Laude, Computer Science & Economics, Washington University in St Louis
Tavis Allison
Grants Advisor
  • Former Director of Strategic Initiatives at Sinai AppLab
  • Former Consultant at Responsive Health
  • Former Program Manager at Mount Sinai Health System
  • Former Director of Grant Development at Mount Sinai School of Medicine
  • M.Sc., Protection Management, John Jay College at CUNY; ABD, Neuroscience, University of California at Los Angeles; B.A., Cognitive Science, Hampshire College
Click Therapeutics, Inc.
Office: (646) 844-2158
For more information, please email:
For career inquiries, please send your CV to: